<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24404" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Lofgren Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brown</surname>
            <given-names>Falon</given-names>
          </name>
          <aff>CUSOM/Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Modi</surname>
            <given-names>Pranav</given-names>
          </name>
          <aff>DY Patil Hospital, Navi Mumbai, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tanner</surname>
            <given-names>Laura S.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Falon Brown declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pranav Modi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Laura Tanner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24404.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Lofgren syndrome is a clinically distinct phenotype of sarcoidosis, first described in 1946 by Swedish pulmonologist Sven Lofgren. Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that commonly involves the lungs with the second most commonly affected organ being the skin. Cutaneous manifestations of sarcoidosis are seen in up to 33% of patients and may be the first clinical sign of the disease. In contrast to the often-insidious onset, slow disease progression and chronic disease course typical of sarcoidosis, Lofgren&#x02019;s syndrome presents acutely. It typically presents in younger patients with acute onset erythema nodosum, bilateral hilar lymphadenopathy, fever, and migratory polyarthritis, and without granulomatous skin involvement. This activity reviews the evaluation and management of patients with Lofgren syndrome and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of Lofgren syndrome.</p></list-item><list-item><p>Outline the presentation of a patient with Lofgren syndrome.</p></list-item><list-item><p>Describe the workup for a patient with Lofgren syndrome.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients with Lofgren syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24404&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24404">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24404.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Lofgren syndrome is a clinically distinct phenotype of sarcoidosis, first described in 1946 by Swedish pulmonologist Sven Lofgren. Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that commonly involves the lungs with the second most commonly affected organ being the skin.<xref ref-type="bibr" rid="article-24404.r1">[1]</xref> Cutaneous manifestations of sarcoidosis are seen in up to 33% of patients and may be the first clinical sign of the disease.<xref ref-type="bibr" rid="article-24404.r2">[2]</xref> In contrast to the often-insidious onset, slow disease progression and chronic disease course typical of sarcoidosis, Lofgren&#x02019;s syndrome presents acutely. It typically presents in younger patients with acute onset erythema nodosum (EN), bilateral hilar lymphadenopathy, fever, and migratory polyarthritis, and without granulomatous skin involvement. Lofgren&#x02019;s syndrome portends a favorable prognosis.<xref ref-type="bibr" rid="article-24404.r3">[3]</xref><xref ref-type="bibr" rid="article-24404.r4">[4]</xref></p>
      </sec>
      <sec id="article-24404.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Etiology and pathophysiology of cutaneous sarcoidosis are poorly understood and attributable to both genetic and environmental factors. Though acute sarcoidosis is not infectious, there is some thought that selected cases may be due to abnormal host reaction to exposure to one or more infective agents, such as <italic toggle="yes">Mycobacterium tuberculosis</italic> or <italic toggle="yes">Propionibacterium</italic> or environmental exposures, such as beryllium, dust, or other occupational agents.<xref ref-type="bibr" rid="article-24404.r5">[5]</xref><xref ref-type="bibr" rid="article-24404.r6">[6]</xref><xref ref-type="bibr" rid="article-24404.r7">[7]</xref></p>
      </sec>
      <sec id="article-24404.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Sarcoidosis affects patients of all ages and races. The incidence and clinical presentation of sarcoidosis differ depending on gender, ethnicity, geographic location, and genetic background. In the United States, women are affected more often than men with an overall African American predominance.<xref ref-type="bibr" rid="article-24404.r8">[8]</xref> Worldwide, the incidence of sarcoidosis is highest in Scandinavians (Sweden and the United Kingdon) and lowest in Spain and Japan.<xref ref-type="bibr" rid="article-24404.r8">[8]</xref></p>
        <p>Lofgren syndrome consistently appears to be more common in females.&#x000a0;It occurs most commonly in European Caucasians, especially patients with Scandinavian descent. Young to middle age adults are more likely to present with this disease with a median age of 37 years old. Specific manifestations of the components of Lofgren syndrome differ based on gender, whereas erythema nodosum is found predominantly in women and arthropathy/arthritis is seen more commonly in men. It classically occurs in the spring months.</p>
      </sec>
      <sec id="article-24404.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In general, sarcoidosis is thought to be a polygenic disorder. The impact of HLA alleles on the pathogenesis of sarcoidosis varies significantly, depending upon disease subtype and racial group. In the case of Lofgren syndrome, HLA-B8/DR3 has a strong association with the disease and also with overall disease resolution.<xref ref-type="bibr" rid="article-24404.r9">[9]</xref></p>
        <p>Despite a rigorous investigation, research has not unveiled a cause or proven pathophysiologic mechanism. The hypothesis is that hosts may have a genetic predisposition but still require exposure to a specific antigen whether it be exogenous or endogenous.&#x000a0;This trigger then activates macrophages and ultimately leads to an exaggerated cellular immune response leading to granuloma formation.&#x000a0;The pathogenesis is very complex and not yet well understood. At the core of the process, T cells play a dominant role in this immune reaction. Studies have shown that granulomas and bronchioloalveolar lavage samples from patients with pulmonary sarcoidosis shown mixed infiltrate with prominent lymphocytosis.<xref ref-type="bibr" rid="article-24404.r10">[10]</xref></p>
        <p>The majority of lymphocytes within sarcoidal granulomas are CD4+T helper 1 (Th1) lymphocytes, contributing to an overall elevated CD4/CD8 ratio.&#x000a0;CD4+T cells secrete interleukin (IL)-2, IL-12, IL-18, and interferon (IFN)-gamma, which in combination with the release of tumor necrosis factor (TNF)-alpha by macrophages and some CD8+T cells, leads to persistent Th1 activity, persistent IFN-gamma elevation and macrophage accumulation within the tissue.&#x000a0;Compartmentalization of granuloma-forming CD4+ T lymphocytes and monocytes/macrophages within peripheral tissues leads to systemic lymphopenia and decreased systemic CD4/CD8 ratio.</p>
        <p>Despite this understanding, the evidence is emerging noting&#x000a0;bronchioloalveolar lavage samples may have&#x000a0;CD4 to CD8 ratio is of less importance because it can increase, be normal, and even decrease.<xref ref-type="bibr" rid="article-24404.r10">[10]</xref> Studies have also noted patients with active sarcoidosis with elevated Th17 to Treg ratio in the peripheral blood and bronchoalveolar lavage fluid.<xref ref-type="bibr" rid="article-24404.r11">[11]</xref></p>
      </sec>
      <sec id="article-24404.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Lofgren syndrome typically does not require a histologic diagnosis.&#x000a0;On pathology, it&#x000a0;similar to other forms of sarcoidosis in that it characteristically presents with non-caseating epithelioid granulomas, usually with a sparse or absent surrounding lymphocytic inflammation, also known as &#x0201c;naked&#x0201d; granulomas, seen on biopsy.<xref ref-type="bibr" rid="article-24404.r12">[12]</xref></p>
      </sec>
      <sec id="article-24404.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Lofgren syndrome is a constellation of the following findings: erythema nodosum, bilateral hilar lymphadenopathy, fever, and migratory polyarthritis.<xref ref-type="bibr" rid="article-24404.r3">[3]</xref> It occasionally also presents with uveitis.<xref ref-type="bibr" rid="article-24404.r3">[3]</xref></p>
        <p>&#x000a0;The arthritis of Lofgren syndrome occurs more often in men, and with periarticular inflammation involving soft tissue and tenosynovitis rather than true arthritis. It typically involves ankles symmetrically but can also involve knees, wrists, and elbow.</p>
        <p>Erythema nodosum presents as painful, bright red, subcutaneous nodules that are typically symmetric on the anterior shins, in contrast to macular/papular sarcoidosis which has a predilection for sites of repetitive trauma. These lesions along with the fever typically remit spontaneously within 6 weeks and may resolve with post-inflammatory hyperpigmentation but without scarring or atrophy. Resolution of lymphadenopathy may delay, taking up to one year, but does resolve completely in 90% of cases.</p>
      </sec>
      <sec id="article-24404.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of sarcoidosis is complex with no definitive test exists. It requires clinical-radiographic correlation, exclusion of alternative disease that can induce granuloma formation, such as tuberculosis, and histologic detection of noncaseating granulomas. There are several specific clinical situations where a presumptive diagnosis can be made based on clinic radiographic findings alone, and biopsy is not considered necessary.<xref ref-type="bibr" rid="article-24404.r13">[13]</xref><xref ref-type="bibr" rid="article-24404.r14">[14]</xref> Bilateral hilar lymphadenopathy, migratory polyarthralgia, erythema nodosum, and fevers of Lofgren syndrome is one such example.<xref ref-type="bibr" rid="article-24404.r15">[15]</xref></p>
        <p>Chest radiography is still necessary to make this diagnosis though may see a variety of alternative pathology other than classic bilateral hilar adenopathy, including unilateral hilar adenopathy or right paratracheal lymphadenopathy with or without pulmonary involvement.</p>
        <p>Should disease deviate from the classic course or fail to resolve within expected time definitive histologic diagnosis may be necessary. The first step in diagnosis should be to determine the most appropriate site for biopsy. Of note, lesions of erythema nodosum will not show sarcoidal granulomas and are therefore not useful biopsy sites to establishing the diagnosis. A comprehensive physical examination should be performed with extra caution taken to examine periorificial sites, including parotid glands, lacrimal glands, and conjunctiva, extremities, sites of previous trauma or tattoos, and full lymph node assessment. Without an easily accessible superficial biopsy site, patients may require a more invasive biopsy method. Alternatively, minimally invasive methods have emerged including flexible bronchoscopy with bronchoalveolar lavage (BAL), endobronchial biopsy, and transbronchial biopsy to assist in the diagnosis of sarcoidosis. Several studies have noted the increased amount of activated CD4+ Th1 cells, decreased CD8+ T cells, and an increase in IgG-secreting plasma cells.&#x000a0;Consequently, a CD4/CD8 ratio greater than 3.5 has been shown to have a 94% specificity for the diagnosis of sarcoidosis.</p>
        <p>Other lab tests are not typically required and remain quite non-specific. Findings may include systemic lymphopenia, elevated levels of calcium, alkaline phosphatase, C-reactive protein (CRP), angiotensin-converting enzyme (ACE), or gamma globulin (polyclonal). Tuberculin skin test or measurement of IFN-gamma in undiluted plasma should be performed in all patients to exclude the diagnosis of tuberculosis which can mimic both erythema nodosum and sarcoidosis.<xref ref-type="bibr" rid="article-24404.r16">[16]</xref> There are reports of thyroid dysfunction in association with cutaneous disease, consider&#x000a0;the evaluation of thyroid function following definitive diagnosis.<xref ref-type="bibr" rid="article-24404.r17">[17]</xref></p>
      </sec>
      <sec id="article-24404.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of Lofgren syndrome is typically supportive with spontaneous resolution occurring over 1 to 2 years. Constitutional symptoms and arthralgias are treatable with non-steroidal anti-inflammatory drug or colchicine. In rare, severe cases may warrant corticosteroids use which can usually be tapered quickly over a few weeks to months.<xref ref-type="bibr" rid="article-24404.r18">[18]</xref></p>
      </sec>
      <sec id="article-24404.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The reaction pattern of fever, arthralgia, and lesions of erythema nodosum, though suggestive are not specific for sarcoidosis. Reactions&#x000a0;may be idiopathic or caused by several other triggers including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Medication-induced causes of penicillin, sulfa drugs, oral contraceptives, immunizations</p>
          </list-item>
          <list-item>
            <p>Infections such as <italic toggle="yes">Streptococcus</italic>, enteric bacteria, <italic toggle="yes">Mycobacterium tuberculosis</italic>, coccidioidomycosis, histoplasmosis, blastomycosis</p>
          </list-item>
          <list-item>
            <p>Other systemic inflammatory diseases like inflammatory bowel disease, lupus, Behcet disease</p>
          </list-item>
          <list-item>
            <p>Pregnancy</p>
          </list-item>
        </list>
        <p>Approximately 10% to 22% of cases of&#x000a0;erythema nodosum are attributable to sarcoidosis. A thorough medical history can help distinguish between many of the above causes of&#x000a0;erythema nodosum. Tuberculosis should be ruled out with either Tuberculin skin test or QuantiFERON gold. Combination of classic radiographic pulmonary findings of bilateral hilar adenopathy can assist in confirming the diagnosis of Lofgren syndrome. As discussed above, if syndrome does not follow the classic timeline alternative diagnosis should be considered, and histologic confirmation of disease is necessary.</p>
      </sec>
      <sec id="article-24404.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Lofgren syndrome portends an excellent prognosis is associated with a greater than 90% chance of spontaneous remission within 2 years.</p>
      </sec>
      <sec id="article-24404.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Lofgren syndrome is a specific acute clinical presentation of systemic sarcoidosis, consisting of a classic triad of fever, erythema nodosum, and bilateral hilar adenopathy; however, this&#x000a0;characteristic triad is not always present and has also been associated with migratory polyarthritis, especially involving ankles in men. Must have a chest radiograph to confirm hilar adenopathy. Otherwise, no specific confirmatory tests are necessary. There is significant overlap among other known etiologies of erythema nodosum which can also contribute to systemic granuloma formation. Should presentation deviate from classic findings listed above further workup and, histopathologic correlation is required. Ultimately, sarcoidosis remains a diagnosis of exclusion.</p>
      </sec>
      <sec id="article-24404.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Sarcoidosis is a multisystem disorder with no known etiology. The diagnosis and management of sarcoidosis, especially Lofgren syndrome, requires a multi-specialty and an interprofessional approach that including dermatology, pulmonology, radiology, and ophthalmology, with assistance from specialty-trained nursing staff and pharmacists who can assist in patient education and coordinating symptomatic&#x000a0;management. This healthcare team approach can lead to better patient outcomes resulting from the delivery of optimal care. [Level V]</p>
      </sec>
      <sec id="article-24404.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24404&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24404">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/lofgren-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24404">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24404/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24404">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24404.s15">
        <fig id="article-24404.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Lofgren syndrome Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lofgren__syndrome" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24404.s16">
        <title>References</title>
        <ref id="article-24404.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siltzbach</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Neville</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Turiaf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Battesti</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>OP</given-names>
              </name>
              <name>
                <surname>Hosoda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mikami</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Odaka</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Course and prognosis of sarcoidosis around the world.</article-title>
            <source>Am J Med</source>
            <year>1974</year>
            <month>Dec</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>847</fpage>
            <page-range>847-52</page-range>
            <pub-id pub-id-type="pmid">4432869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wanat</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Rosenbach</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Sarcoidosis.</article-title>
            <source>Clin Chest Med</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>685</fpage>
            <page-range>685-702</page-range>
            <pub-id pub-id-type="pmid">26593142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ponhold</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>[The L&#x000f6;fgren syndrome: acute sarcoidosis (author's transl)].</article-title>
            <source>Rontgenblatter</source>
            <year>1977</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>325</fpage>
            <page-range>325-7</page-range>
            <pub-id pub-id-type="pmid">897518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>JAMES</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>THOMSON</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>WILLCOX</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Erythema nodosum as a manifestation of sarcoidosis.</article-title>
            <source>Lancet</source>
            <year>1956</year>
            <month>Aug</month>
            <day>04</day>
            <volume>271</volume>
            <issue>6936</issue>
            <fpage>218</fpage>
            <page-range>218-21</page-range>
            <pub-id pub-id-type="pmid">13347112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferrara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Valentini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wahlstr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Grunewald</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Brighenti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dodoo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zumla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maeurer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and L&#x000f6;fgren's syndrome using high-content peptide microarrays.</article-title>
            <source>Int J Infect Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>56</volume>
            <fpage>167</fpage>
            <page-range>167-175</page-range>
            <pub-id pub-id-type="pmid">28159576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishige</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Eishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takemura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nakata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nagaoka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iwai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takizawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koike</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis.</article-title>
            <source>Sarcoidosis Vasc Diffuse Lung Dis</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-42</page-range>
            <pub-id pub-id-type="pmid">15881278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newman</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Bresnitz</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Rossman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frederick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Terrin</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Weinberger</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Moller</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>McLennan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hunninghake</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>DePalo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Judson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Knatterud</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Teirstein</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Yeager</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Johns</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Rabin</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Rybicki</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Cherniack</surname>
                <given-names>R</given-names>
              </name>
              <collab>ACCESS Research Group</collab>
            </person-group>
            <article-title>A case control etiologic study of sarcoidosis: environmental and occupational risk factors.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2004</year>
            <month>Dec</month>
            <day>15</day>
            <volume>170</volume>
            <issue>12</issue>
            <fpage>1324</fpage>
            <page-range>1324-30</page-range>
            <pub-id pub-id-type="pmid">15347561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newman</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Maier</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis.</article-title>
            <source>N Engl J Med</source>
            <year>1997</year>
            <month>Apr</month>
            <day>24</day>
            <volume>336</volume>
            <issue>17</issue>
            <fpage>1224</fpage>
            <page-range>1224-34</page-range>
            <pub-id pub-id-type="pmid">9110911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spagnolo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Grunewald</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brynedal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hillert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma&#x000f1;&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Eklund</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Welsh</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>du Bois</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for L&#x000f6;fgren's syndrome.</article-title>
            <source>J Intern Med</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>264</volume>
            <issue>5</issue>
            <fpage>433</fpage>
            <page-range>433-41</page-range>
            <pub-id pub-id-type="pmid">18513341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Linssen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Bronchoalveolar lavage in sarcoidosis.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>486</fpage>
            <page-range>486-95</page-range>
            <pub-id pub-id-type="pmid">17975776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mortaz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rezayat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Amani</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kiani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garssen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Adcock</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Velayati</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The Roles of T Helper 1, T Helper 17 and Regulatory T Cells in the Pathogenesis of Sarcoidosis.</article-title>
            <source>Iran J Allergy Asthma Immunol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>334</fpage>
            <page-range>334-339</page-range>
            <pub-id pub-id-type="pmid">27921415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cardoso</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Cravo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Tellechea</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous sarcoidosis: a histopathological study.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>678</fpage>
            <page-range>678-82</page-range>
            <pub-id pub-id-type="pmid">19298487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <article-title>Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>160</volume>
            <issue>2</issue>
            <fpage>736</fpage>
            <page-range>736-55</page-range>
            <pub-id pub-id-type="pmid">10430755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma&#x000f1;&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Vaquero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Montero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salazar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marcoval</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Valverde</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manresa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pujol</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>L&#x000f6;fgren's syndrome revisited: a study of 186 patients.</article-title>
            <source>Am J Med</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>107</volume>
            <issue>3</issue>
            <fpage>240</fpage>
            <page-range>240-5</page-range>
            <pub-id pub-id-type="pmid">10492317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MAYOCK</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>BERTRAND</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>MORRISON</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>SCOTT</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>MANIFESTATIONS OF SARCOIDOSIS. ANALYSIS OF 145 PATIENTS, WITH A REVIEW OF NINE SERIES SELECTED FROM THE LITERATURE.</article-title>
            <source>Am J Med</source>
            <year>1963</year>
            <month>Jul</month>
            <volume>35</volume>
            <fpage>67</fpage>
            <page-range>67-89</page-range>
            <pub-id pub-id-type="pmid">14046006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LOFGREN</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>LUNDBACK</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The bilateral hilar lymphoma syndrome; a study of the relation to tuberculosis and sarcoidosis in 212 cases.</article-title>
            <source>Acta Med Scand</source>
            <year>1952</year>
            <month>Mar</month>
            <day>19</day>
            <volume>142</volume>
            <issue>4</issue>
            <fpage>265</fpage>
            <page-range>265-73</page-range>
            <pub-id pub-id-type="pmid">14932794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anolik</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Schaffer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Rosenbach</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Thyroid dysfunction and cutaneous sarcoidosis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>167</fpage>
            <page-range>167-8</page-range>
            <pub-id pub-id-type="pmid">22177644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24404.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zisman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Shorr</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis involving the musculoskeletal system.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>555</fpage>
            <page-range>555-70</page-range>
            <pub-id pub-id-type="pmid">16088651</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
